{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1127, 
        1136
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1511, 
        1534
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1038, 
        1065
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1068, 
        1072
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        497, 
        526
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1682, 
        1717
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        917, 
        943
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1110, 
        1118
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1073, 
        1079
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1119, 
        1126
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        974, 
        983
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1094, 
        1106
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 1^9999^MOH|PIMS|CCO|20160602153805|38CE6ED8ACDB4C887D219DFDD297C66675DE5485|ORU^R01|Q1933557086T3639495324|P|2.5|\nPID|1||J9999999^^^^CMR^HOSPITAL 1&9999&MOH~J9999999^^^^MRN^HOSPITAL 1&9999&MOH~9999999999&L&ON^^^^JHN||XXXXXX^XXXXXXX||99999999|F|||9 XXXXX XX^^XXXXXX^XXX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||S-16-0023516|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160527|||61097^XXXXXXXX^XXXXX||||||||||N||20160602|||F|||||||99999^XXXXXX^XXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n\nThe specimen and patient identifiers are reviewed and are verified.\nTissue excised on 2016/05/27 at 1340 h\nTissue fixed on 2016/05/27 at 1355 h\nIschemic time: 15 m\nTotal fixation time: 75 h 5 m\nSpecimen: pale tan, white and yellow core(s)\n   Number: 3\n   Size: 1.8 to 0.9 cm\nSection code (entirely submitted): (A1).\nGross examination by Kathleen Rooney, MLT /jm 2016/05/30 12:18:40 EDT\n\n\nPath report.site of origin\n\n\nA Breast core biopsy, left, 2 o'clock, lt braest 2 oclock mass, highly suspicious for IDC\n\n\nPath report.final diagnosis\n\n\nLeft breast core biopsies at 2 o'clock:\n- invasive mammary carcinoma of no special type\n- estimated SBR grade 1/3\n- positive for estrogen receptor protein (greater than 90%, moderate to strong) \n- positive for progesterone receptor protein (greater than 90%, moderate to strong)\n- equivocal for HER2/NEU protein overexpression by immunohistochemistry\n- FISH for HER2/NEU gene amplification pending - see separate cytogenetics report.  BW/jm\n\n\nPath report.relevant Hx\n\n\nThe following information was submitted electronically by the ordering physician:\nlt braest 2 oclock mass, highly suspicious for ID \ner/pr/her\n\n\nPath report.microscopic observation\n\n\nExamination of tissue sections prepared from the left breast core biopsies at 2 o'clock reveal an invasive mammary carcinoma no special type with estimated SBR grade 1 (tubular formation 2, nuclear pleomorphism - 2, mitotic activity - 1). Background ductal carcinoma in situ is not evident. Calcifications are identified associated with invasive tumour.\n\n\n"
}